Your doctor will determine the right starting dose, monitor your progress, and adjust your prescription as needed
Patients should be aware of the following safety considerations: Contact your GP or dietitian if you are consistently losing more than approximately 1 kg per week (or more than 1% of your body weight per week), in line with NHS guidance on safe rates of weight loss, as this may indicate insufficient calorie or protein intake
recorded over 6,700 cases of pancreatitis linked to GLP-1 drugs between 2005 and 2023, raising alarms among healthcare providers and Ozempic lawyers
Importantly, semaglutide should not be used with other GLP-1 receptor agonists or with other semaglutide-containing products
If your semaglutide has been exposed to heat, look for visual changes
Clinical Category Guidance & Safety Mandates Thyroid History Warning Strictly contraindicated if you or anyone in your family has a history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)